Status
Conditions
About
To analyze Volatile Organic Compounds (VOCs) in the breath of patients with SARS-CoV-2 and controls in SARS-CoV-2 breath specimens.
Full description
The study is a prospective cohort study, which enrol patients presenting to hospital and are tested for SARS-CoV-2. There will be two cohorts, COVID-19 positive and COVID-19 negative, who will have exhaled breath collection and analysis by infrared spectroscopy to characterize the composition of VOCs and identify differences in VOC profiles between the two groups.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria for Covid-19 positive patients:
Inclusion criteria for Covid-19 negative patients:
Exclusion Criteria for Covid-19 positive and negative patients:
200 participants in 2 patient groups
Loading...
Central trial contact
Gail Gauvreau, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal